Optical Magnification in the Age of Digital Microscopy Figure 1: Displaying the same image on two different monitors immediately reveals the difference in optical magnification. Share this Post: Introduction January 14, 2019 – Study of the minuscule is not possible without aid of an instrument because the human retina does not possess sufficient angular resolution […]
Read MoreCategory: blog
Whole Slide Imaging: A Crash Course by Reveal Biosciences
Whole Slide Imaging: A Crash Course Reveal Biosciences The Digital Pathology Association recently released a white paper that provides a comprehensive overview of whole slide imaging, including the challenges and advantages of implementing this technology into existing workflows. We’ve assembled the essential details in this article as a crash course on whole slide imaging. What […]
Read MoreCatalent Receives P&G External Business Partner of the Year Award
Catalent Receives P&G External Business Partner of the Year Award SOMERSET, N.J. – February 18, 2019— Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the […]
Read MoreAvomeen Whitepaper
Biologics White Paper PDF
Read MorePrecision Histology: Artificial Intelligence as a Tool for Pathologists by Reveal Biosciences
Precision Histology: Artificial Intelligence as a Tool for Pathologists The hematoxylin and eosin (H&E) stain has long been an essential tool in the pathologist’s arsenal. Positively-charged hematoxylin and negatively-charged eosin bind to different substances within a tissue sample. This allows pathologists to clearly view different structures within that sample in various shades of blue, violet, […]
Read MoreCatalent Invests $200 Million to Expand Biologics Capacity and Capabilities
Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities SOMERSET, N.J. – January 7, 2019— Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has commenced a $200 million capital investment in its Biologics business to expand drug […]
Read MoreV I V A Biotech Partnering Reception
V I V A Biotech Partnering Reception Seed and Early-Stage Biotech Investment Experienced | Efficient | Focused Great Track Record: 25+ biotech start-ups in the portfolio Genesis @ 4242 Campus Point, San Diego, Nov. 14, 2018 On Nov. 14th, 2018, Viva Biotech held its inaugural Partnering Reception in San Diego, one of the biotech hubs […]
Read MoreOncology Webinar by Simbec-Orion
View On Demand Webinar – ESMO Update: State of the Art in Early Phase Oncology Trial Design Simbec-Orion Group Ltd
Read More